Mesa Laboratories, Inc.
MLAB
$107.64
$1.601.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.83M | -4.14M | 3.63M | 2.48M | 4.74M |
| Total Depreciation and Amortization | 5.65M | 5.75M | 5.72M | 5.85M | 5.96M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.34M | 8.42M | 4.93M | 5.35M | -855.00K |
| Change in Net Operating Assets | 2.93M | 3.93M | 4.48M | -5.45M | -7.95M |
| Cash from Operations | 14.74M | 13.96M | 18.75M | 8.22M | 1.89M |
| Capital Expenditure | -559.00K | -417.00K | -732.00K | -1.09M | -1.01M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -559.00K | -417.00K | -732.00K | -1.09M | -1.01M |
| Total Debt Issued | 10.00M | 0.00 | 0.00 | 97.00M | 10.50M |
| Total Debt Repaid | -18.66M | -14.69M | -8.69M | -103.44M | -7.44M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -958.00K | -1.06M | -- | -- | -1.06M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -884.00K | -884.00K | -884.00K | -882.00K | -873.00K |
| Other Financing Activities | -- | 873.00K | -214.00K | -564.00K | -9.56M |
| Cash from Financing | -10.50M | -15.76M | -9.79M | -7.88M | -8.43M |
| Foreign Exchange rate Adjustments | 88.00K | 167.00K | 316.00K | -104.00K | 1.50M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.77M | -2.05M | 8.55M | -857.00K | -6.04M |